US20160089531A1 - Electrode lead including a deployable tissue anchor - Google Patents
Electrode lead including a deployable tissue anchor Download PDFInfo
- Publication number
- US20160089531A1 US20160089531A1 US14/947,502 US201514947502A US2016089531A1 US 20160089531 A1 US20160089531 A1 US 20160089531A1 US 201514947502 A US201514947502 A US 201514947502A US 2016089531 A1 US2016089531 A1 US 2016089531A1
- Authority
- US
- United States
- Prior art keywords
- rotatable member
- lead body
- deployable
- central axis
- deployable member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000007246 mechanism Effects 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- 210000001519 tissue Anatomy 0.000 description 32
- 239000004020 conductor Substances 0.000 description 7
- 238000002513 implantation Methods 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000034347 Faecal incontinence Diseases 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical group [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0558—Anchoring or fixation means therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0587—Epicardial electrode systems; Endocardial electrodes piercing the pericardium
- A61N1/059—Anchoring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0507—Electrodes for the digestive system
- A61N1/0512—Anal electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0507—Electrodes for the digestive system
- A61N1/0514—Electrodes for the urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
- A61N2001/058—Fixing tools
Definitions
- Embodiments of the present invention generally relate to an anchor that facilitates securing devices or components to internal tissue of a patient and preventing migration of the devices or components from their intended location relative to the tissue of the patient.
- Implantable electronic stimulator devices such as neuromuscular stimulation devices, have been disclosed for use in the treatment of various pelvic conditions, such as urinary incontinence, fecal incontinence and sexual dysfunction.
- Such devices generally include one or more electrodes that are coupled to a control unit by electrode leads. Electrical signals are applied to the desired pelvic tissue of the patient through the electrode leads in order to treat the condition of the patient.
- Exemplary implantable electronic stimulator devices and uses of the devices are disclosed in U.S. Pat. Nos. 6,354,991, 6,652,449, 6,712,772 and 6,862,480, each of which is hereby incorporated by reference in its entirety.
- Anchors to secure the one or more electrodes in tissue of the patient.
- exemplary anchors include helical coils and mesh, such as that disclosed in (A92.12-0136), which is incorporated herein by reference in its entirety. It is desirable, for example, that such anchors prevent relative movement between the anchor and the tissue in which the anchor in embedded, are easy to install in the tissue, avoid damaging the tissue during the implantation procedure, can be removed without significantly damaging the tissue, and/or have other features or benefits recognized by those skilled in the art.
- Embodiments of the invention are directed to an implantable electrode lead.
- the electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism.
- the rotatable member is contained within a distal end of the tubular lead body.
- the deployable member is attached to the rotatable member and comprises a tissue anchor.
- the deployment mechanism is configured to drive the deployable member along a central axis and out the distal end of the tubular lead body responsive to rotation of the rotatable member about the central axis.
- the deployable member does not rotate about the central axis with the rotation of the rotatable member.
- the electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism.
- the rotatable member is contained within a distal end of the tubular lead body.
- the deployable member is attached to the rotatable member and comprises a tissue anchor.
- the distal end of the tubular lead body is positioned proximate target tissue of a patient.
- the rotatable member is rotated relative to the tubular lead body.
- the deployable member is driven along the central axis, out the distal end of the tubular lead body, and into the target tissue using the deployment mechanism responsive to the rotation of the rotatable member.
- the deployable member does not rotate about the central axis with the rotation of the rotatable member.
- FIG. 1 is a side plan view of an exemplary electronic stimulator device, in accordance with embodiments of the invention.
- FIGS. 2 and 3 are simplified views of an electrode lead formed in accordance with embodiments of the invention positioned within tissue of a patient.
- FIG. 4 is a simplified side view of a distal end of an electrode lead having a mesh anchor in a deployed position, in accordance with embodiments of the invention.
- FIG. 5 is a cross-sectional view of the portion of the lead of FIG. 4 taken generally along line 5 - 5 .
- FIG. 6 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention.
- FIG. 7 is a cross-sectional view of the electrode lead of FIG. 6 taken generally along line 7 - 7 .
- FIG. 8 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention.
- FIG. 9 is a flowchart illustrating a method of using the electrode lead formed in accordance with one or more embodiments of the invention.
- FIG. 1 is a side plan view of an exemplary electronic stimulator device 100 , in accordance with embodiments of the invention.
- the stimulator device 100 is configured for implantation into a pelvic region of a patient to provide muscle and/or nerve stimulation that is used to control and/or treat a pelvic condition of the patient, such as pelvic pain, urinary incontinence, fecal incontinence, erectile dysfunction or other pelvic condition that may be treated through electrical stimulation.
- the device 100 comprises a control unit 102 and one or more electrode leads 104 , a proximal end 106 of which is electrically coupled to the control unit 102 via a connector 108 .
- the electrode lead 104 comprises a tubular lead body 110 and one or more stimulation elements or electrodes 112 supported at a distal end 114 by the lead body 110 .
- the electrodes 112 are separated from each other by an insulative portion or element 116 .
- the lead body 110 insulates electrical wires 118 or other conductor that connects the control unit 102 to the electrodes 112 .
- the lead body 110 can be in the form of an insulating jacket typically comprising silicone, polyurethane or other flexible, biocompatible electrically insulating material. Additional electrode leads 104 or physiological sensors may be coupled to the control unit 102 .
- control unit 102 comprises circuitry including at least one processor for processing electrical signals received from the one or more electrodes 112 or physiological sensors (not shown). In one embodiment, the control unit 102 is also configured to apply an electrical current or waveform to the tissue of the patient through the one or more electrodes 112 that are in contact with the tissue. In one embodiment, the control unit 102 receives power from an internal battery (not shown).
- control unit 102 is enclosed within a hermetically sealed metal housing 113 commonly referred to as a “can.”
- the can 113 generally comprises first and second halves that are joined together in a laser-welding operation about their perimeters after the battery power supply and electronic circuitry are inserted in the space defined by the two halves of the can.
- a header 115 includes a connector block that may be molded in the header or inserted after the header has been molded. Feed-through conductors from the electronic circuitry within the can are coupled to electrical contacts of the connector block.
- the connector block includes one or more ports, each of which receives the connector 108 of each lead 104 and electrically couples the connector 108 to the electronic circuitry or control unit 102 contained within the can 113 via the feed-through conductors.
- the distal end 114 of the electrode lead 104 can be anchored to pelvic tissue of the patient (e.g., urinary sphincter muscle, anal sphincter muscle, etc.) by means of a tissue anchor 120 , in accordance with embodiments of the invention.
- a tissue anchor 120 in accordance with embodiments of the invention.
- Embodiments of the anchor include a helical coil, mesh and other suitable components.
- the anchor 120 operates to secure the position of the electrodes 112 in the desired tissue of the patient.
- the anchor 120 is attached to a deployable member 122 that may be deployed from within the tubular lead body, as illustrated in FIG. 1 .
- the deployable member 122 includes the one or more electrodes 112 , as shown in FIG. 1 .
- the deployable member 122 has a retracted position, in which the deployable member 122 is received within the tubular lead body 110 , as shown in the simplified side view of FIG. 2 . While in this retracted position, the distal end 114 of the electrode lead 104 may be implanted in tissue 124 of a patient, as shown in the simplified side view of FIG. 3 . The implantation of the distal end 114 of the electrode lead 104 may be accomplished using conventional techniques, such as with an introducer needle. Once the distal end 114 of the electrode lead 104 is positioned as desired within the tissue 124 , the physician may use a deployment mechanism to move the deployable member 122 out an opening 126 of the tubular lead member 110 , as illustrated in FIGS. 1 and 3 .
- the tissue anchor 120 is attached to the deployable member 122 and comprises mesh, as illustrated in FIG. 3 .
- FIG. 4 is a simplified side view of the distal end 114 of the electrode lead 104 with the deployable member 122 having the mesh anchor 120 in the deployed position within tissue 124 of a patient.
- FIG. 5 is a cross-sectional view of the deployable member 122 taken generally along line 5 - 5 of FIG. 4 and illustrates the implantation of the distal end 114 of the electrode lead 104 .
- the mesh anchor 120 is preferably a bio-compatible open matrix mesh, such as a mesh constructed of polypropylene monofilament. A portion of the mesh anchor 120 is attached to the deployable member 122 at a location 128 . Exemplary means for attaching the mesh anchor 120 to the deployable member 122 include sutures, glue, anchors, or other suitable bio-compatible methods.
- the mesh anchor 120 comprises one or more mesh sections or wings, such as wings 130 and 132 .
- the mesh anchor 120 has a compact state and an expanded state.
- the mesh anchor 120 is placed in the compact state when retracted within the tubular lead 110 ( FIG. 2 ).
- the deployable member 122 is moved through the opening 126 , the mesh anchor 120 expands, as shown in FIGS. 3-5 , to promote tissue ingrowth through the mesh and anchor the deployable member 122 and the distal end 114 of the electrode lead 104 in place within the tissue 124 .
- at least a portion of the mesh anchor 120 is displaced a greater distance from the deployable member 122 when in the expanded state than when in the compact state.
- the mesh anchor 120 has a shape memory that drives the mesh to a preset expanded, quiescent shape, in which at least a portion of the mesh anchor 120 extends away from the deployable member 122 and into the surrounding tissue 124 .
- the “quiescent shape” of the mesh anchor 120 is one in which the mesh will naturally return to after being deformed, such as when compressed into a compact state.
- the expanded state of the mesh wings 130 and 132 is one in which the wings 130 and 132 are displaced from each other, such as illustrated FIG. 5 .
- a nitinol structure is secured to the mesh and promotes the expansion of the mesh.
- one embodiment of the mesh anchor 120 has a shape memory that encourages separation of the one or more wings, such as wings 130 and 132 , within the tissue 124 .
- the mesh anchor 120 comprises the one or more electrodes 112 that are used to deliver electrical signals to the tissue 124 .
- one or more conductive fibers 134 are attached to the mesh anchor 120 and conduct electrical signals from the deployable member 122 , such as electrodes 112 on the deployable member 122 , to the tissue 124 , as shown in FIG. 4 .
- the conductive fibers 134 are electrically insulated from the tissue 124 and conduct the electrical signals to one or more electrically conductive nodes or electrodes 136 that are attached to the mesh anchor 120 and deliver the electrical signals to the tissue 124 .
- FIG. 6 is a simplified side cross-sectional view of a distal end 114 of an electrode lead 104 in accordance with embodiments of the invention.
- FIG. 7 is a cross-sectional view of the electrode lead 104 of FIG. 6 taken generally along line 7 - 7 .
- the lead 104 comprises the tubular lead body 110 , a rotatable member 138 within the distal end 114 of the tubular lead body 110 , the deployable member 122 , and a deployment mechanism 139 .
- electrode lead 104 includes one or more electrodes 112 that are supported by the lead body 110 , such as through the attachment of the electrodes 112 to the lead body 110 , or to the deployable member 122 , for example.
- the electrodes 112 are not illustrated in FIG. 6 or 7 in order to simplify the drawings.
- the rotatable member 138 is configured to rotate about a central axis 140 , which is generally aligned with the longitudinal axis of the tubular lead body 110 .
- a distal end 142 of the rotatable member 138 is attached to the deployable member 122 .
- the electrode lead 104 includes an extension member 144 having a distal end 146 that is attached to a proximal end 148 of the rotatable member 138 , as shown in FIG. 6 .
- the extension member 144 has a proximal end 150 that extends to the proximal end 106 of the tubular lead body 104 , as shown in FIG. 2 .
- a physician may rotate the proximal end 150 of the extension member 144 by hand to drive the rotation of the rotatable member 138 about the central axis 140 .
- a motorized device or other tool may be used to drive the rotation of the proximal end 150 .
- the extension member 144 comprises a coil, as illustrated in FIG. 6 .
- At least one electrical conductor extends through the tubular lead body 110 and is electrically coupled to the one or more electrodes 112 .
- the rotatable member 138 is formed of or includes an electrically conductive material that conducts electrical signals to the one or more electrodes 112 through the deployable member 122 .
- the extension member 144 is used to conduct the electrical signals to the rotatable member 138 .
- separate electrical conductors such as wires 118 ( FIG. 1 ) may extend through the lead body 110 to the rotatable member 138 .
- Other configurations are also possible.
- the deployment mechanism 139 is configured to drive the deployable member 122 along the central axis 140 responsive to the rotation of the rotatable member 138 about the central axis 140 to move the deployable member 122 between the retracted position ( FIG. 2 ) and the deployed position ( FIGS. 1 and 3 ).
- the deployment mechanism 139 comprises a threaded section 160 of the rotatable member 138 and a threaded section 162 of the deployable member 122 , as shown in FIG. 6 .
- the threaded section 160 of the rotatable member 138 is located on an exterior surface of the rotatable member 138
- the threaded section 162 is located on an interior surface of a bore 164 of the deployable member 122 .
- this arrangement may be reversed by placing the threaded section 160 of the rotatable member 138 on an interior surface of a bore, and arranging the threaded section 162 of the deployable member 122 on an exterior surface that is received within the bore of the rotatable member 138 .
- the threaded sections 160 and 162 intermesh and the rotation of the rotatable member 138 about the central axis 140 relative to the deployable member 122 drives the deployable member 122 along the central axis 140 relative to the rotatable member 138 and the tubular lead body 110 .
- the position of the rotatable member 138 along the central axis 140 is fixed relative to the tubular lead body 110 . In one embodiment, this is accomplished using one or more stop members 166 of the lead body 110 that engage a member 168 of the rotatable member 138 , as shown in FIG. 6 .
- the electrode lead 104 includes a guide 170 that is configured to prevent the deployable member 122 from rotating about the central axis 140 relative to the lead body 110 .
- the guide 170 comprises a slot 172 in an exterior wall 174 of the deployable member 122 , and a protrusion 176 extending from an interior wall 178 of the lead body 110 , as shown in FIGS. 6 and 7 .
- the protrusion 176 slides within the slot 172 and prevents the deployable member 122 from rotating about the central axis 140 relative to the lead body 110 .
- the deployable member 122 does not rotate about the central axis 140 with the rotation of the rotatable member 138 .
- the electrode lead 104 includes a pair of the guides 170 , as shown in FIGS. 6 and 7 . Additional guides may also be used as necessary.
- FIG. 8 is a simplified side cross-sectional view of a distal end 114 of electrode lead 104 in accordance with embodiments of the invention.
- the deployable member 122 is coupled to the distal end 142 through a suitable mechanical connection.
- the mechanical connection allows the deployable member 122 to remain in a fixed angular position about the central axis 140 as the rotatable member 138 rotates about the axis 140 .
- the mechanical coupling between the deployable member 122 and the rotatable member 138 can take on many different forms while providing the desired function described above.
- the mechanical coupling comprises a ball member 186 coupled to the rotatable member 138 , and a socket member 188 coupled to the deployable member 122 .
- the ball member 186 is received within the socket member 188 and is able to rotate within the socket member 188 .
- a low friction interface 190 is formed between the exterior surface of the ball member 186 and the interior surface of the socket member 188 .
- the low friction interface 190 may be formed using a suitable lubricant, an insert covering the exterior of the ball member 186 , an insert covering the interior surface of the socket member 188 , and/or other suitable techniques for forming a low friction interface.
- the deployable member 122 is restricted from rotating about the axis 140 relative to the lead body 110 .
- the lead 104 includes one or more of the guides 170 described above, as shown in FIG. 8 .
- FIG. 8 Another embodiment of the deployment mechanism 139 , illustrated in FIG. 8 , comprises a threaded section 194 on the interior wall 178 of the tubular lead member 110 , and a threaded section 196 on the exterior surface 198 of the rotatable member 138 .
- the threaded sections 194 and 196 are positioned to intermesh with each other. Rotation of the rotatable member 138 about the axis 140 drives movement of the rotatable member 138 along the axis 140 relative to the lead body 110 .
- the rotation of the rotatable member 138 about the axis 140 also drives movement of the deployable member 122 along the axis 140 .
- the deployment mechanism 139 drives movement of the deployable member 122 along the axis 140 relative to the lead body 110 through the rotation of the rotatable member 138 , and it may be used to deploy the deployable member 122 from within the lead body 110 through the opening 126 into desired tissue of a patient, and retract the deployable member 122 back into the lead body 110 through the opening 126 , as described above.
- the movement of the rotatable member 138 along the central axis 140 is restricted by one or more stops 200 projecting from the interior wall 178 of the lead body 110 and stops 202 extending radially from the rotatable member 138 .
- the stops 200 of the lead body 110 engage the stops 202 to limit the distance the rotatable member 138 may travel along the central axis 140 and, thus, the distance the deployable member 122 may travel along the axis 140 relative to the tubular lead member 110 .
- the deployable member 122 and/or the connected anchor 120 may include the one or more electrodes or stimulation elements 112 .
- electrical signals are delivered to the one or more electrodes 112 on the deployable member 122 through an electrical conductive path that extends to the proximal end 106 of the tubular lead body 110 .
- the electrical signals are conducted to the rotatable member 138 using, for example, the extension member 144 , or other suitable conductor.
- an electrical connection is formed between the rotatable member 138 and the deployable member 122 such that electrical signals conducted to the rotatable member 138 may be delivered to the one or more electrodes 112 that are connected to the deployable member 122 .
- the electrical connection comprises a coil 204 or other suitable component that rotates about the central axis 140 with the rotation of the rotatable member 138 .
- the coil 204 or other suitable component is placed in sliding contact with the deployable member 122 to conduct electrical signals from the rotatable member 138 to the deployable member 122 .
- the electrical connection allows electrical signals to be delivered to the one or more electrodes 112 through the deployable member 122 while maintaining the ability to rotate the rotatable member 138 relative to the deployable member 122 .
- the electrical connection is formed between the ball member 186 and the socket member 188 .
- FIG. 9 is a flowchart illustrating a method of using the electrode lead 104 formed in accordance with one or more embodiments described above.
- an electrode lead 104 formed in accordance with one or more of the embodiments described above is provided.
- the distal end 114 of the tubular lead member 110 is positioned approximate target tissue 124 of a patient, as shown in FIG. 2 .
- the rotatable member 138 is rotated relative to the tubular lead member 110 . As discussed above, this may be accomplished through the rotation of the proximal end 143 of the extension member 138 by the physician.
- the deployable member 122 is driven along the central axis 140 and out the opening 146 at the distal end 114 of the tubular lead member 110 using the deployment mechanism 139 , as shown in FIG. 3 .
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
- The present application claims the benefit of U.S. provisional patent application Ser. No. 61/494,950 filed Jun. 9, 2011, the content of which is hereby incorporated by reference in its entirety.
- Embodiments of the present invention generally relate to an anchor that facilitates securing devices or components to internal tissue of a patient and preventing migration of the devices or components from their intended location relative to the tissue of the patient.
- Implantable electronic stimulator devices, such as neuromuscular stimulation devices, have been disclosed for use in the treatment of various pelvic conditions, such as urinary incontinence, fecal incontinence and sexual dysfunction. Such devices generally include one or more electrodes that are coupled to a control unit by electrode leads. Electrical signals are applied to the desired pelvic tissue of the patient through the electrode leads in order to treat the condition of the patient. Exemplary implantable electronic stimulator devices and uses of the devices are disclosed in U.S. Pat. Nos. 6,354,991, 6,652,449, 6,712,772 and 6,862,480, each of which is hereby incorporated by reference in its entirety.
- Electrical leads utilize anchors to secure the one or more electrodes in tissue of the patient. Exemplary anchors include helical coils and mesh, such as that disclosed in (A92.12-0136), which is incorporated herein by reference in its entirety. It is desirable, for example, that such anchors prevent relative movement between the anchor and the tissue in which the anchor in embedded, are easy to install in the tissue, avoid damaging the tissue during the implantation procedure, can be removed without significantly damaging the tissue, and/or have other features or benefits recognized by those skilled in the art.
- Embodiments of the invention are directed to an implantable electrode lead. In some embodiments, the electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism. The rotatable member is contained within a distal end of the tubular lead body. The deployable member is attached to the rotatable member and comprises a tissue anchor. The deployment mechanism is configured to drive the deployable member along a central axis and out the distal end of the tubular lead body responsive to rotation of the rotatable member about the central axis. In one embodiment, the deployable member does not rotate about the central axis with the rotation of the rotatable member.
- Another embodiment is directed to a method, in which an electrode lead is provided. The electrode lead comprises a tubular lead body, an electrode supported by the lead body, a rotatable member, a deployable member and a deployment mechanism. The rotatable member is contained within a distal end of the tubular lead body. The deployable member is attached to the rotatable member and comprises a tissue anchor. Also in the method, the distal end of the tubular lead body is positioned proximate target tissue of a patient. The rotatable member is rotated relative to the tubular lead body. The deployable member is driven along the central axis, out the distal end of the tubular lead body, and into the target tissue using the deployment mechanism responsive to the rotation of the rotatable member. In one embodiment, the deployable member does not rotate about the central axis with the rotation of the rotatable member.
-
FIG. 1 is a side plan view of an exemplary electronic stimulator device, in accordance with embodiments of the invention. -
FIGS. 2 and 3 are simplified views of an electrode lead formed in accordance with embodiments of the invention positioned within tissue of a patient. -
FIG. 4 is a simplified side view of a distal end of an electrode lead having a mesh anchor in a deployed position, in accordance with embodiments of the invention. -
FIG. 5 is a cross-sectional view of the portion of the lead ofFIG. 4 taken generally along line 5-5. -
FIG. 6 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention. -
FIG. 7 is a cross-sectional view of the electrode lead ofFIG. 6 taken generally along line 7-7. -
FIG. 8 is a simplified side cross-sectional view of a distal end of an electrode lead, in accordance with embodiments of the invention. -
FIG. 9 is a flowchart illustrating a method of using the electrode lead formed in accordance with one or more embodiments of the invention. - Embodiments of the invention are described more fully hereinafter with reference to the accompanying drawings. The various embodiments of the invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Elements that are identified using the same or similar reference characters refer to the same or similar elements.
-
FIG. 1 is a side plan view of an exemplaryelectronic stimulator device 100, in accordance with embodiments of the invention. Thestimulator device 100 is configured for implantation into a pelvic region of a patient to provide muscle and/or nerve stimulation that is used to control and/or treat a pelvic condition of the patient, such as pelvic pain, urinary incontinence, fecal incontinence, erectile dysfunction or other pelvic condition that may be treated through electrical stimulation. - In one embodiment, the
device 100 comprises acontrol unit 102 and one or more electrode leads 104, aproximal end 106 of which is electrically coupled to thecontrol unit 102 via aconnector 108. In one embodiment, theelectrode lead 104 comprises atubular lead body 110 and one or more stimulation elements orelectrodes 112 supported at adistal end 114 by thelead body 110. In one embodiment, theelectrodes 112 are separated from each other by an insulative portion orelement 116. Thelead body 110 insulateselectrical wires 118 or other conductor that connects thecontrol unit 102 to theelectrodes 112. Thelead body 110 can be in the form of an insulating jacket typically comprising silicone, polyurethane or other flexible, biocompatible electrically insulating material. Additional electrode leads 104 or physiological sensors may be coupled to thecontrol unit 102. - In one embodiment, the
control unit 102 comprises circuitry including at least one processor for processing electrical signals received from the one ormore electrodes 112 or physiological sensors (not shown). In one embodiment, thecontrol unit 102 is also configured to apply an electrical current or waveform to the tissue of the patient through the one ormore electrodes 112 that are in contact with the tissue. In one embodiment, thecontrol unit 102 receives power from an internal battery (not shown). - In one embodiment, the
control unit 102 is enclosed within a hermetically sealedmetal housing 113 commonly referred to as a “can.” Thecan 113 generally comprises first and second halves that are joined together in a laser-welding operation about their perimeters after the battery power supply and electronic circuitry are inserted in the space defined by the two halves of the can. - A
header 115 includes a connector block that may be molded in the header or inserted after the header has been molded. Feed-through conductors from the electronic circuitry within the can are coupled to electrical contacts of the connector block. The connector block includes one or more ports, each of which receives theconnector 108 of eachlead 104 and electrically couples theconnector 108 to the electronic circuitry orcontrol unit 102 contained within thecan 113 via the feed-through conductors. - The
distal end 114 of theelectrode lead 104 can be anchored to pelvic tissue of the patient (e.g., urinary sphincter muscle, anal sphincter muscle, etc.) by means of atissue anchor 120, in accordance with embodiments of the invention. Embodiments of the anchor include a helical coil, mesh and other suitable components. Theanchor 120 operates to secure the position of theelectrodes 112 in the desired tissue of the patient. - In one embodiment, the
anchor 120 is attached to adeployable member 122 that may be deployed from within the tubular lead body, as illustrated inFIG. 1 . In one embodiment, thedeployable member 122 includes the one ormore electrodes 112, as shown inFIG. 1 . - In one embodiment, the
deployable member 122 has a retracted position, in which thedeployable member 122 is received within thetubular lead body 110, as shown in the simplified side view ofFIG. 2 . While in this retracted position, thedistal end 114 of theelectrode lead 104 may be implanted intissue 124 of a patient, as shown in the simplified side view ofFIG. 3 . The implantation of thedistal end 114 of theelectrode lead 104 may be accomplished using conventional techniques, such as with an introducer needle. Once thedistal end 114 of theelectrode lead 104 is positioned as desired within thetissue 124, the physician may use a deployment mechanism to move thedeployable member 122 out anopening 126 of thetubular lead member 110, as illustrated inFIGS. 1 and 3 . - In one embodiment, the
tissue anchor 120 is attached to thedeployable member 122 and comprises mesh, as illustrated inFIG. 3 .FIG. 4 is a simplified side view of thedistal end 114 of theelectrode lead 104 with thedeployable member 122 having themesh anchor 120 in the deployed position withintissue 124 of a patient.FIG. 5 is a cross-sectional view of thedeployable member 122 taken generally along line 5-5 ofFIG. 4 and illustrates the implantation of thedistal end 114 of theelectrode lead 104. In one embodiment, themesh anchor 120 is preferably a bio-compatible open matrix mesh, such as a mesh constructed of polypropylene monofilament. A portion of themesh anchor 120 is attached to thedeployable member 122 at alocation 128. Exemplary means for attaching themesh anchor 120 to thedeployable member 122 include sutures, glue, anchors, or other suitable bio-compatible methods. In one embodiment, themesh anchor 120 comprises one or more mesh sections or wings, such aswings - In one embodiment, the
mesh anchor 120 has a compact state and an expanded state. Themesh anchor 120 is placed in the compact state when retracted within the tubular lead 110 (FIG. 2 ). When thedeployable member 122 is moved through theopening 126, themesh anchor 120 expands, as shown inFIGS. 3-5 , to promote tissue ingrowth through the mesh and anchor thedeployable member 122 and thedistal end 114 of theelectrode lead 104 in place within thetissue 124. In general, at least a portion of themesh anchor 120 is displaced a greater distance from thedeployable member 122 when in the expanded state than when in the compact state. - In one embodiment, the
mesh anchor 120 has a shape memory that drives the mesh to a preset expanded, quiescent shape, in which at least a portion of themesh anchor 120 extends away from thedeployable member 122 and into the surroundingtissue 124. As used herein, the “quiescent shape” of themesh anchor 120 is one in which the mesh will naturally return to after being deformed, such as when compressed into a compact state. In one embodiment, the expanded state of themesh wings wings FIG. 5 . In one embodiment, a nitinol structure is secured to the mesh and promotes the expansion of the mesh. Thus, one embodiment of themesh anchor 120 has a shape memory that encourages separation of the one or more wings, such aswings tissue 124. - In one embodiment, the
mesh anchor 120 comprises the one ormore electrodes 112 that are used to deliver electrical signals to thetissue 124. In one embodiment, one or moreconductive fibers 134 are attached to themesh anchor 120 and conduct electrical signals from thedeployable member 122, such aselectrodes 112 on thedeployable member 122, to thetissue 124, as shown inFIG. 4 . In one embodiment, theconductive fibers 134 are electrically insulated from thetissue 124 and conduct the electrical signals to one or more electrically conductive nodes orelectrodes 136 that are attached to themesh anchor 120 and deliver the electrical signals to thetissue 124. -
FIG. 6 is a simplified side cross-sectional view of adistal end 114 of anelectrode lead 104 in accordance with embodiments of the invention.FIG. 7 is a cross-sectional view of theelectrode lead 104 ofFIG. 6 taken generally along line 7-7. In one embodiment, thelead 104 comprises the tubularlead body 110, arotatable member 138 within thedistal end 114 of the tubularlead body 110, thedeployable member 122, and adeployment mechanism 139. In one embodiment,electrode lead 104 includes one ormore electrodes 112 that are supported by thelead body 110, such as through the attachment of theelectrodes 112 to thelead body 110, or to thedeployable member 122, for example. Theelectrodes 112 are not illustrated inFIG. 6 or 7 in order to simplify the drawings. - In one embodiment, the
rotatable member 138 is configured to rotate about acentral axis 140, which is generally aligned with the longitudinal axis of the tubularlead body 110. In one embodiment, adistal end 142 of therotatable member 138 is attached to thedeployable member 122. In one embodiment, theelectrode lead 104 includes anextension member 144 having adistal end 146 that is attached to aproximal end 148 of therotatable member 138, as shown inFIG. 6 . In one embodiment, theextension member 144 has aproximal end 150 that extends to theproximal end 106 of the tubularlead body 104, as shown inFIG. 2 . A physician may rotate theproximal end 150 of theextension member 144 by hand to drive the rotation of therotatable member 138 about thecentral axis 140. Alternatively, a motorized device or other tool may be used to drive the rotation of theproximal end 150. In one embodiment, theextension member 144 comprises a coil, as illustrated inFIG. 6 . - In one embodiment, at least one electrical conductor extends through the tubular
lead body 110 and is electrically coupled to the one ormore electrodes 112. In one embodiment, when the one ormore electrodes 112 are disposed in or on thedeployable member 122, or are otherwise electrically coupled to thedeployable member 122, therotatable member 138 is formed of or includes an electrically conductive material that conducts electrical signals to the one ormore electrodes 112 through thedeployable member 122. In one embodiment, theextension member 144 is used to conduct the electrical signals to therotatable member 138. Alternatively, separate electrical conductors, such as wires 118 (FIG. 1 ) may extend through thelead body 110 to therotatable member 138. Other configurations are also possible. - One embodiment of the
deployment mechanism 139 is configured to drive thedeployable member 122 along thecentral axis 140 responsive to the rotation of therotatable member 138 about thecentral axis 140 to move thedeployable member 122 between the retracted position (FIG. 2 ) and the deployed position (FIGS. 1 and 3 ). In one embodiment, thedeployment mechanism 139 comprises a threadedsection 160 of therotatable member 138 and a threadedsection 162 of thedeployable member 122, as shown inFIG. 6 . In one embodiment, the threadedsection 160 of therotatable member 138 is located on an exterior surface of therotatable member 138, and the threadedsection 162 is located on an interior surface of abore 164 of thedeployable member 122. However, it is understood that this arrangement may be reversed by placing the threadedsection 160 of therotatable member 138 on an interior surface of a bore, and arranging the threadedsection 162 of thedeployable member 122 on an exterior surface that is received within the bore of therotatable member 138. - In one embodiment, the threaded
sections rotatable member 138 about thecentral axis 140 relative to thedeployable member 122 drives thedeployable member 122 along thecentral axis 140 relative to therotatable member 138 and the tubularlead body 110. This allows thedeployable member 122 to be deployed from within the tubularlead body 110 through theopening 126, or retracted into the tubularlead body 110, through the rotation of therotatable member 138, which is driven, for example, by the rotation of theextension portion 144. - In one embodiment, the position of the
rotatable member 138 along thecentral axis 140 is fixed relative to the tubularlead body 110. In one embodiment, this is accomplished using one ormore stop members 166 of thelead body 110 that engage amember 168 of therotatable member 138, as shown inFIG. 6 . - In one embodiment, the
electrode lead 104 includes aguide 170 that is configured to prevent thedeployable member 122 from rotating about thecentral axis 140 relative to thelead body 110. In one embodiment, theguide 170 comprises aslot 172 in anexterior wall 174 of thedeployable member 122, and aprotrusion 176 extending from aninterior wall 178 of thelead body 110, as shown inFIGS. 6 and 7 . As thedeployable member 122 is moved along thecentral axis 140 relative to thelead body 110 responsive to the rotation of therotatable member 138, theprotrusion 176 slides within theslot 172 and prevents thedeployable member 122 from rotating about thecentral axis 140 relative to thelead body 110. As a result, thedeployable member 122 does not rotate about thecentral axis 140 with the rotation of therotatable member 138. In one embodiment, theelectrode lead 104 includes a pair of theguides 170, as shown inFIGS. 6 and 7 . Additional guides may also be used as necessary. -
FIG. 8 is a simplified side cross-sectional view of adistal end 114 ofelectrode lead 104 in accordance with embodiments of the invention. In one embodiment, thedeployable member 122 is coupled to thedistal end 142 through a suitable mechanical connection. In one embodiment, the mechanical connection allows thedeployable member 122 to remain in a fixed angular position about thecentral axis 140 as therotatable member 138 rotates about theaxis 140. The mechanical coupling between thedeployable member 122 and therotatable member 138 can take on many different forms while providing the desired function described above. - In one exemplary embodiment, the mechanical coupling comprises a
ball member 186 coupled to therotatable member 138, and asocket member 188 coupled to thedeployable member 122. Theball member 186 is received within thesocket member 188 and is able to rotate within thesocket member 188. In one embodiment, alow friction interface 190 is formed between the exterior surface of theball member 186 and the interior surface of thesocket member 188. Thelow friction interface 190 may be formed using a suitable lubricant, an insert covering the exterior of theball member 186, an insert covering the interior surface of thesocket member 188, and/or other suitable techniques for forming a low friction interface. - In one embodiment, the
deployable member 122 is restricted from rotating about theaxis 140 relative to thelead body 110. In one embodiment, thelead 104 includes one or more of theguides 170 described above, as shown inFIG. 8 . - Another embodiment of the
deployment mechanism 139, illustrated inFIG. 8 , comprises a threadedsection 194 on theinterior wall 178 of thetubular lead member 110, and a threadedsection 196 on theexterior surface 198 of therotatable member 138. The threadedsections rotatable member 138 about theaxis 140 drives movement of therotatable member 138 along theaxis 140 relative to thelead body 110. Due to the mechanical coupling between thedistal end 142 of therotatable member 138 and thedeployable member 122, the rotation of therotatable member 138 about theaxis 140 also drives movement of thedeployable member 122 along theaxis 140. Thus, thedeployment mechanism 139 drives movement of thedeployable member 122 along theaxis 140 relative to thelead body 110 through the rotation of therotatable member 138, and it may be used to deploy thedeployable member 122 from within thelead body 110 through theopening 126 into desired tissue of a patient, and retract thedeployable member 122 back into thelead body 110 through theopening 126, as described above. - In one embodiment, the movement of the
rotatable member 138 along thecentral axis 140 is restricted by one ormore stops 200 projecting from theinterior wall 178 of thelead body 110 and stops 202 extending radially from therotatable member 138. Thestops 200 of thelead body 110 engage thestops 202 to limit the distance therotatable member 138 may travel along thecentral axis 140 and, thus, the distance thedeployable member 122 may travel along theaxis 140 relative to thetubular lead member 110. - As discussed above, the
deployable member 122 and/or theconnected anchor 120 may include the one or more electrodes orstimulation elements 112. As discussed above, electrical signals are delivered to the one ormore electrodes 112 on thedeployable member 122 through an electrical conductive path that extends to theproximal end 106 of the tubularlead body 110. In one embodiment, the electrical signals are conducted to therotatable member 138 using, for example, theextension member 144, or other suitable conductor. In one embodiment, an electrical connection is formed between therotatable member 138 and thedeployable member 122 such that electrical signals conducted to therotatable member 138 may be delivered to the one ormore electrodes 112 that are connected to thedeployable member 122. In one embodiment, the electrical connection comprises acoil 204 or other suitable component that rotates about thecentral axis 140 with the rotation of therotatable member 138. Thecoil 204 or other suitable component is placed in sliding contact with thedeployable member 122 to conduct electrical signals from therotatable member 138 to thedeployable member 122. The electrical connection allows electrical signals to be delivered to the one ormore electrodes 112 through thedeployable member 122 while maintaining the ability to rotate therotatable member 138 relative to thedeployable member 122. In accordance with another embodiment, the electrical connection is formed between theball member 186 and thesocket member 188. -
FIG. 9 is a flowchart illustrating a method of using theelectrode lead 104 formed in accordance with one or more embodiments described above. At 210, anelectrode lead 104 formed in accordance with one or more of the embodiments described above is provided. At 212, thedistal end 114 of thetubular lead member 110 is positionedapproximate target tissue 124 of a patient, as shown inFIG. 2 . At 214, therotatable member 138 is rotated relative to thetubular lead member 110. As discussed above, this may be accomplished through the rotation of the proximal end 143 of theextension member 138 by the physician. At 216, thedeployable member 122 is driven along thecentral axis 140 and out theopening 146 at thedistal end 114 of thetubular lead member 110 using thedeployment mechanism 139, as shown inFIG. 3 . - Although the present invention has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/947,502 US20160089531A1 (en) | 2011-06-09 | 2015-11-20 | Electrode lead including a deployable tissue anchor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161494950P | 2011-06-09 | 2011-06-09 | |
US13/490,600 US9220887B2 (en) | 2011-06-09 | 2012-06-07 | Electrode lead including a deployable tissue anchor |
US14/947,502 US20160089531A1 (en) | 2011-06-09 | 2015-11-20 | Electrode lead including a deployable tissue anchor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/490,600 Division US9220887B2 (en) | 2011-06-09 | 2012-06-07 | Electrode lead including a deployable tissue anchor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160089531A1 true US20160089531A1 (en) | 2016-03-31 |
Family
ID=47293799
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/490,600 Active 2033-05-18 US9220887B2 (en) | 2011-06-09 | 2012-06-07 | Electrode lead including a deployable tissue anchor |
US14/947,502 Abandoned US20160089531A1 (en) | 2011-06-09 | 2015-11-20 | Electrode lead including a deployable tissue anchor |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/490,600 Active 2033-05-18 US9220887B2 (en) | 2011-06-09 | 2012-06-07 | Electrode lead including a deployable tissue anchor |
Country Status (1)
Country | Link |
---|---|
US (2) | US9220887B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013537835A (en) | 2010-09-28 | 2013-10-07 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | Devices and methods for positioning electrodes in tissue |
US9981121B2 (en) | 2014-04-28 | 2018-05-29 | Medtronic, Inc. | Implantable medical devices, systems and components thereof |
EP3139994B1 (en) * | 2014-05-09 | 2024-05-22 | Merit Medical Systems, Inc. | Device for positioning an electrode in a body cavity |
US10709886B2 (en) * | 2017-02-28 | 2020-07-14 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
US10835739B2 (en) | 2017-03-24 | 2020-11-17 | Boston Scientific Neuromodulation Corporation | Electrical stimulation leads and systems with elongate anchoring elements and methods of making and using |
US11565105B2 (en) * | 2018-10-05 | 2023-01-31 | Biotronik Se & Co. Kg | Lead anchor for a neuromodulation lead |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4257428A (en) * | 1977-12-09 | 1981-03-24 | Barton Steven A | Retractable stimulation electrode apparatus and method |
US20020151948A1 (en) * | 1998-04-30 | 2002-10-17 | Medtronic, Inc. | Apparatus and method for expanding a simulation lead body in situ |
US20070050003A1 (en) * | 2005-08-30 | 2007-03-01 | Cardiac Pacemakers, Inc. | Device on lead to prevent perforation and/or fixate lead |
US20100049289A1 (en) * | 2007-07-10 | 2010-02-25 | Ams Research Corporation | Tissue anchor |
Family Cites Families (283)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3667477A (en) | 1966-11-25 | 1972-06-06 | Canadian Patents Dev | Implantable vesical stimulator |
GB1227186A (en) | 1968-09-18 | 1971-04-07 | ||
CH507005A (en) | 1969-03-26 | 1971-05-15 | Inst Medicina Farmacie | Device for electrical neurostimulation for the evacuation of the neurogenic urinary bladder |
US3662758A (en) | 1969-06-30 | 1972-05-16 | Mentor Corp | Stimulator apparatus for muscular organs with external transmitter and implantable receiver |
US3646940A (en) | 1969-07-15 | 1972-03-07 | Univ Minnesota | Implantable electronic stimulator electrode and method |
US3640284A (en) | 1970-01-05 | 1972-02-08 | Philip A De Langis | Apparatus for electrotherapy of the pubococcygeus |
GB1434524A (en) | 1972-04-27 | 1976-05-05 | Nat Res Dev | Urinary control apparatus |
GB1452262A (en) | 1972-07-13 | 1976-10-13 | Devices Implants Ltd | Pessary ring electrode system |
US3941136A (en) | 1973-11-21 | 1976-03-02 | Neuronyx Corporation | Method for artificially inducing urination, defecation, or sexual excitation |
AT332528B (en) | 1974-10-18 | 1976-10-11 | Nemec Hans | ELECTROMEDICAL APPARATUS |
US3926178A (en) | 1975-01-17 | 1975-12-16 | Alvin N Feldzamen | Apparatus for aiding the voluntary exercising of sphincter muscles |
US3983865A (en) | 1975-02-05 | 1976-10-05 | Shepard Richard S | Method and apparatus for myofunctional biofeedback |
US3983881A (en) | 1975-05-21 | 1976-10-05 | Telectronics Pty. Limited | Muscle stimulator |
US4010758A (en) | 1975-09-03 | 1977-03-08 | Medtronic, Inc. | Bipolar body tissue electrode |
US4030509A (en) | 1975-09-30 | 1977-06-21 | Mieczyslaw Mirowski | Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization |
US3999555A (en) | 1975-10-28 | 1976-12-28 | Medtronic, Inc. | Atrial pinch on lead and insertion tool |
US4044774A (en) | 1976-02-23 | 1977-08-30 | Medtronic, Inc. | Percutaneously inserted spinal cord stimulation lead |
SE7604553L (en) | 1976-04-21 | 1977-10-22 | Svenska Utvecklings Ab | ELECTRICAL STIMULATOR FOR REDUCING INCONTINENCE |
US4136684A (en) | 1977-02-07 | 1979-01-30 | Scattergood Mark G | Linear electromyographic biofeedback system |
US4139006A (en) | 1977-03-18 | 1979-02-13 | Corey Arthur E | Female incontinence device |
US4222377A (en) | 1977-06-27 | 1980-09-16 | American Medical Systems, Inc. | Pressure regulated artificial sphincter systems |
US4217913A (en) | 1977-10-10 | 1980-08-19 | Medtronic, Inc. | Body-implantable lead with protected, extendable tissue securing means |
US4153059A (en) | 1977-10-25 | 1979-05-08 | Minnesota Mining And Manufacturing Company | Urinary incontinence stimulator system |
US4157087A (en) | 1978-03-06 | 1979-06-05 | Med General, Inc. | Peripheral nerve stimulator |
US4165750A (en) | 1978-03-18 | 1979-08-28 | Aleev Leonid S | Bioelectrically controlled electric stimulator of human muscles |
US4177819A (en) | 1978-03-30 | 1979-12-11 | Kofsky Harvey I | Muscle stimulating apparatus |
US4290420A (en) | 1980-06-09 | 1981-09-22 | Alberto Manetta | Stress incontinence diagnostic and treatment device |
SE435679B (en) | 1980-09-17 | 1984-10-15 | Landskrona Finans Ab | STIMULATOR SYSTEM, INCLUDING ONE OF A RECHARGEABLE BATTERY DRIVE PULSE GENERATOR |
YU272580A (en) | 1980-10-23 | 1982-10-31 | Inst Jozef Stefan | Control circuit of a therapeutic stimulator for urine incontinency |
GB2099304B (en) | 1981-02-06 | 1985-01-30 | Cornwell George Herbert Ivan | Incontinence control devices |
US4406288A (en) | 1981-04-06 | 1983-09-27 | Hugh P. Cash | Bladder control device and method |
US4402328A (en) | 1981-04-28 | 1983-09-06 | Telectronics Pty. Limited | Crista terminalis atrial electrode lead |
US4750494A (en) | 1981-05-12 | 1988-06-14 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
US4414986A (en) | 1982-01-29 | 1983-11-15 | Medtronic, Inc. | Biomedical stimulation lead |
US4688575A (en) | 1982-03-12 | 1987-08-25 | Duvall Wilbur E | Muscle contraction stimulation |
US4492233A (en) | 1982-09-14 | 1985-01-08 | Wright State University | Method and apparatus for providing feedback-controlled muscle stimulation |
US4731083A (en) | 1982-09-21 | 1988-03-15 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4571749A (en) | 1982-09-21 | 1986-02-25 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
EP0109217A1 (en) | 1982-11-05 | 1984-05-23 | Craig Medical Products Limited | Female incontinence device |
US4542753A (en) | 1982-12-22 | 1985-09-24 | Biosonics, Inc. | Apparatus and method for stimulating penile erectile tissue |
US4515167A (en) | 1983-02-28 | 1985-05-07 | Hochman Joel S | Device for the development, training and rehabilitation of the pubococcygeal and related perineal musculature of the female |
DE3317118C2 (en) | 1983-05-06 | 1986-08-28 | Richard Wolf Gmbh, 7134 Knittlingen | Device for the treatment of the female incontinentia urinae |
US4550737A (en) | 1983-10-12 | 1985-11-05 | Peter Osypka | Intravenously implantable electrode lead for use with cardiac pacemakers |
US4585005A (en) | 1984-04-06 | 1986-04-29 | Regents Of University Of California | Method and pacemaker for stimulating penile erection |
US4607639A (en) | 1984-05-18 | 1986-08-26 | Regents Of The University Of California | Method and system for controlling bladder evacuation |
US4739764A (en) | 1984-05-18 | 1988-04-26 | The Regents Of The University Of California | Method for stimulating pelvic floor muscles for regulating pelvic viscera |
US4771779A (en) | 1984-05-18 | 1988-09-20 | The Regents Of The University Of California | System for controlling bladder evacuation |
US4703755A (en) | 1984-05-18 | 1987-11-03 | The Regents Of The University Of California | Control system for the stimulation of two bodily functions |
US4602624A (en) | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
US4628942A (en) | 1984-10-11 | 1986-12-16 | Case Western Reserve University | Asymmetric shielded two electrode cuff |
US4590949A (en) | 1984-11-01 | 1986-05-27 | Cordis Corporation | Neural stimulating lead with stabilizing mechanism and method for using same |
US4569351A (en) | 1984-12-20 | 1986-02-11 | University Of Health Sciences/The Chicago Medical School | Apparatus and method for stimulating micturition and certain muscles in paraplegic mammals |
DE3673644D1 (en) | 1986-05-12 | 1990-09-27 | Univ California | ELECTRONIC SYSTEM FOR NERVOUS STIMULATION OF PELVIC ORGANS. |
US4785828A (en) | 1986-10-06 | 1988-11-22 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
DE3802158A1 (en) | 1987-08-11 | 1989-02-23 | Hoechst Ag | DEVICE FOR APPLICATION OF IMPLANTS |
DK162185C (en) | 1987-09-15 | 1998-02-23 | Linda Jonasson | Device for preventing involuntary discharge of urine |
US4881526A (en) | 1988-05-27 | 1989-11-21 | Empi, Inc. | Intravaginal electrode and stimulation system for controlling female urinary incontinence |
US5125925A (en) | 1988-08-03 | 1992-06-30 | Photoradiation Systems | Intracavity laser catheter with sensing fiber |
US4913164A (en) | 1988-09-27 | 1990-04-03 | Intermedics, Inc. | Extensible passive fixation mechanism for lead assembly of an implantable cardiac stimulator |
WO1990003766A1 (en) | 1988-10-04 | 1990-04-19 | Peter Emanuel Petros | Surgical instrument prosthesis and method of utilisation of such |
US5094242A (en) | 1988-11-07 | 1992-03-10 | Regents Of The University Of California | Implantable nerve stimulation device |
US5013292A (en) | 1989-02-24 | 1991-05-07 | R. Laborie Medical Corporation | Surgical correction of female urinary stress incontinence and kit therefor |
NL8901046A (en) | 1989-04-26 | 1990-11-16 | Enraf Nonius Delft | ELECTRODE FOR STIMULATING AND / OR DETECTING THE MUSCULAR ACTIVITY OF A PATIENT'S ACCESSIBLE MUSCLES OR MUSCULAR GROUPS THROUGH A BODY OPEN. |
US5061265A (en) | 1989-06-20 | 1991-10-29 | University Of Florida | Laser treatment apparatus and method |
US5074632A (en) | 1990-03-07 | 1991-12-24 | Health Research, Inc. | Fiber optic diffusers and methods for manufacture of the same |
US5019032A (en) | 1990-04-03 | 1991-05-28 | Robertson Jack R | Refined suspension procedure with implement for treating female stress incontinence |
JPH0724668B2 (en) | 1990-05-02 | 1995-03-22 | 明夫 山田 | Urinary incontinence prevention monitor |
EP0459945B1 (en) | 1990-05-26 | 1997-11-19 | MED-EL Medical Electronics Elektro-medizinische Geräte GmbH | Neuromuscular electrical stimulation device |
US5169396A (en) | 1990-06-08 | 1992-12-08 | Kambiz Dowlatshahi | Method for interstitial laser therapy |
US5520606A (en) | 1990-10-18 | 1996-05-28 | Schoolman; Arnold | Mechanical urinary sphincter device |
US5269777A (en) | 1990-11-01 | 1993-12-14 | Pdt Systems, Inc. | Diffusion tip for optical fibers |
US6524274B1 (en) | 1990-12-28 | 2003-02-25 | Scimed Life Systems, Inc. | Triggered release hydrogel drug delivery system |
US5102402A (en) | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
US6131575A (en) | 1991-01-10 | 2000-10-17 | The Procter & Gamble Company | Urinary incontinence device |
US5199430A (en) | 1991-03-11 | 1993-04-06 | Case Western Reserve University | Micturitional assist device |
US5452719A (en) | 1991-07-23 | 1995-09-26 | Eisman; Eugene | Multiple electrode myographic probe and method |
US5533508A (en) | 1991-10-31 | 1996-07-09 | Pdt Systems, Inc. | Vivo dosimeter for photodynamic therapy |
DE69323779T2 (en) | 1991-12-03 | 1999-09-30 | Boston Scientific Ireland Ltd., Saint Michael | Instrument for passing a sewing thread |
US5439467A (en) | 1991-12-03 | 1995-08-08 | Vesica Medical, Inc. | Suture passer |
US5312439A (en) | 1991-12-12 | 1994-05-17 | Loeb Gerald E | Implantable device having an electrolytic storage electrode |
US5358514A (en) | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5193540A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Structure and method of manufacture of an implantable microstimulator |
US5193539A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
US5330507A (en) | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
EP0680283B1 (en) | 1992-04-24 | 1998-05-13 | Surgical Laser Technologies | Thermally-resistant medical probe |
US5505687A (en) | 1992-05-14 | 1996-04-09 | The United States Of America As Represented By The Department Of Health And Human Services | Device for measuring incident light in a body cavity |
GB9211085D0 (en) | 1992-05-23 | 1992-07-08 | Tippey Keith E | Electrical stimulation |
US5324324A (en) | 1992-10-13 | 1994-06-28 | Siemens Pacesetter, Inc. | Coated implantable stimulation electrode and lead |
US5344439A (en) | 1992-10-30 | 1994-09-06 | Medtronic, Inc. | Catheter with retractable anchor mechanism |
US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
US5291902A (en) | 1993-01-11 | 1994-03-08 | Brent Carman | Incontinence treatment |
US5428699A (en) | 1993-07-02 | 1995-06-27 | Laserscope | Probe having optical fiber for laterally directing laser beam |
US5484445A (en) | 1993-10-12 | 1996-01-16 | Medtronic, Inc. | Sacral lead anchoring system |
US5400784A (en) | 1993-10-15 | 1995-03-28 | Case Western Reserve University | Slowly penetrating inter-fascicular nerve cuff electrode and method of using |
US5370670A (en) | 1993-12-13 | 1994-12-06 | Thomas Jefferson University | Detrusor myoplasty and neuromuscular electrical stimulation of the urinary bladder |
US5458595A (en) | 1993-12-16 | 1995-10-17 | The Regents Of The University Of California | Vaginal speculum for photodynamic therapy and method of using the same |
JP2591032Y2 (en) | 1993-12-20 | 1999-02-24 | 株式会社モリテックス | Optical fiber laser light guide diffuser probe |
US5518504A (en) | 1993-12-28 | 1996-05-21 | American Medical Systems, Inc. | Implantable sphincter system utilizing lifting means |
US5411016A (en) | 1994-02-22 | 1995-05-02 | Scimed Life Systems, Inc. | Intravascular balloon catheter for use in combination with an angioscope |
DK0676218T3 (en) | 1994-03-25 | 2002-10-07 | Novartis Ag | Light diffuses and methods of making them |
US5423329A (en) | 1994-04-15 | 1995-06-13 | Rehab Centers Of America, Inc. | Method of treatment for urinary incontinence |
EP1217101B8 (en) | 1994-04-29 | 2006-02-01 | Boston Scientific Scimed, Inc. | Stent with collagen |
US5417226A (en) | 1994-06-09 | 1995-05-23 | Juma; Saad | Female anti-incontinence device |
US5733277A (en) | 1994-06-22 | 1998-03-31 | Pallarito; Allan L. | Optical fibre and laser for removal of arterial or vascular obstructions |
US5603685A (en) | 1994-07-01 | 1997-02-18 | Tutrone, Jr.; Donald F. | Inflatable vaginal pessary |
US5431647A (en) | 1994-07-13 | 1995-07-11 | Pioneer Optics Company | Fiberoptic cylindrical diffuser |
US5593405A (en) | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5571148A (en) | 1994-08-10 | 1996-11-05 | Loeb; Gerald E. | Implantable multichannel stimulator |
US5899909A (en) | 1994-08-30 | 1999-05-04 | Medscand Medical Ab | Surgical instrument for treating female urinary incontinence |
SE506164C2 (en) | 1995-10-09 | 1997-11-17 | Medscand Medical Ab | Instruments for the treatment of urinary incontinence in women |
US5833595A (en) | 1994-09-06 | 1998-11-10 | Lin; Vernon Wen-Hau | Treatment of excretory problems |
US6270492B1 (en) | 1994-09-09 | 2001-08-07 | Cardiofocus, Inc. | Phototherapeutic apparatus with diffusive tip assembly |
US6572609B1 (en) | 1999-07-14 | 2003-06-03 | Cardiofocus, Inc. | Phototherapeutic waveguide apparatus |
US6423055B1 (en) | 1999-07-14 | 2002-07-23 | Cardiofocus, Inc. | Phototherapeutic wave guide apparatus |
US5569351A (en) | 1994-11-14 | 1996-10-29 | Cms Gilbreth Packaging Systems, Inc. | Banding machine having improved film registration system |
US5591217A (en) | 1995-01-04 | 1997-01-07 | Plexus, Inc. | Implantable stimulator with replenishable, high value capacitive power source and method therefor |
NL9500495A (en) | 1995-03-13 | 1996-10-01 | Cordis Europ | Balloon catheter with a single lumen and assembly of such a catheter and a light guide. |
NL9500516A (en) | 1995-03-15 | 1996-10-01 | Cordis Europ | Balloon catheter with light-guiding basic body. |
DK46595A (en) | 1995-04-21 | 1996-10-22 | Multicept Aps | Vibrator |
US5824005A (en) | 1995-08-22 | 1998-10-20 | Board Of Regents, The University Of Texas System | Maneuverable electrophysiology catheter for percutaneous or intraoperative ablation of cardiac arrhythmias |
US5947958A (en) | 1995-09-14 | 1999-09-07 | Conceptus, Inc. | Radiation-transmitting sheath and methods for its use |
CA2229620A1 (en) | 1995-11-24 | 1997-05-29 | Advanced Bionics Corporation | System and method for conditioning pelvic musculature using an implanted microstimulator |
US5658327A (en) * | 1995-12-19 | 1997-08-19 | Ventritex, Inc. | Intracardiac lead having a compliant fixation device |
US5891136A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Expandable-collapsible mesh electrode structures |
GB9601383D0 (en) | 1996-01-24 | 1996-03-27 | Lenadora Shantha J B | Device for genuine stress incontinence in the female |
DE69725484T2 (en) | 1996-02-15 | 2004-07-15 | Nihon Kohden Corp. | Device for the treatment of urinary incontinence |
US6051017A (en) | 1996-02-20 | 2000-04-18 | Advanced Bionics Corporation | Implantable microstimulator and systems employing the same |
US5728092A (en) | 1996-03-07 | 1998-03-17 | Miravant Systems, Inc. | Light delivery catheter |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6013053A (en) | 1996-05-17 | 2000-01-11 | Qlt Photo Therapeutics Inc. | Balloon catheter for photodynamic therapy |
US6146409A (en) | 1996-05-20 | 2000-11-14 | Bergein F. Overholt | Therapeutic methods and devices for irradiating columnar environments |
US5876426A (en) | 1996-06-13 | 1999-03-02 | Scimed Life Systems, Inc. | System and method of providing a blood-free interface for intravascular light delivery |
US5854422A (en) | 1996-07-10 | 1998-12-29 | K-Line Industries, Inc. | Ultrasonic detector |
US5957920A (en) | 1997-08-28 | 1999-09-28 | Isothermix, Inc. | Medical instruments and techniques for treatment of urinary incontinence |
AU4107297A (en) | 1996-09-05 | 1998-03-26 | Governors Of The University Of Alberta, The | Gastro-intestinal electrical pacemaker |
JP2002515793A (en) | 1996-10-23 | 2002-05-28 | オーレイテック インターヴェンションズ インコーポレイテッド | Method and apparatus for treating an intervertebral disc |
EP0846474B1 (en) | 1996-10-30 | 2003-08-27 | Nihon Kohden Corporation | Stimulating apparatus for preventing urinary incontinence |
US5911720A (en) | 1996-11-26 | 1999-06-15 | Ep Technologies, Inc. | Ablation catheter with segmented tip |
US6026326A (en) | 1997-01-13 | 2000-02-15 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
AU6329598A (en) | 1997-02-13 | 1998-09-08 | Boston Scientific Ireland Limited, Barbados Head Office | Stabilization sling for use in minimally invasive pelvic surgery |
US6208894B1 (en) | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
WO1998037926A1 (en) | 1997-02-26 | 1998-09-03 | Alfred E. Mann Foundation For Scientific Research | Battery-powered patient implantable device |
US5957965A (en) | 1997-03-03 | 1999-09-28 | Medtronic, Inc. | Sacral medical electrical lead |
US6039686A (en) | 1997-03-18 | 2000-03-21 | Kovac; S. Robert | System and a method for the long term cure of recurrent urinary female incontinence |
US5954761A (en) | 1997-03-25 | 1999-09-21 | Intermedics Inc. | Implantable endocardial lead assembly having a stent |
US5766222A (en) | 1997-07-07 | 1998-06-16 | Petit; Michael G. | Nipple illuminator for photodynamic therapy |
US6135945A (en) | 1997-08-04 | 2000-10-24 | Sultan; Hashem | Anti-incontinence device |
US5824027A (en) | 1997-08-14 | 1998-10-20 | Simon Fraser University | Nerve cuff having one or more isolated chambers |
US6096030A (en) | 1997-09-23 | 2000-08-01 | Pharmacyclics, Inc. | Light delivery catheter and PDT treatment method |
US7628795B2 (en) | 1997-09-24 | 2009-12-08 | Atrium Medical Corporation | Tunneling device for use with a graft |
US6149636A (en) | 1998-06-29 | 2000-11-21 | The Procter & Gamble Company | Disposable article having proactive sensors |
US6104955A (en) | 1997-12-15 | 2000-08-15 | Medtronic, Inc. | Method and apparatus for electrical stimulation of the gastrointestinal tract |
US6212434B1 (en) | 1998-07-22 | 2001-04-03 | Cardiac Pacemakers, Inc. | Single pass lead system |
US6501994B1 (en) | 1997-12-24 | 2002-12-31 | Cardiac Pacemakers, Inc. | High impedance electrode tip |
US6141594A (en) | 1998-07-22 | 2000-10-31 | Cardiac Pacemakers, Inc. | Single pass lead and system with active and passive fixation elements |
US5997571A (en) | 1997-12-17 | 1999-12-07 | Cardiofocus, Inc. | Non-occluding phototherapy probe stabilizers |
US6299609B1 (en) | 1998-01-07 | 2001-10-09 | Vasca, Inc. | Methods and apparatus for inhibiting infection of subcutaneously implanted devices |
US6321116B1 (en) | 1998-02-08 | 2001-11-20 | Seung Kee Mo | Electrical apparatus medical treatment using EMG envelope signal |
US5931864A (en) | 1998-02-20 | 1999-08-03 | Cardiac Pacemakers, Inc. | Coronary venous lead having fixation mechanism |
US6382214B1 (en) | 1998-04-24 | 2002-05-07 | American Medical Systems, Inc. | Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele |
US20050255039A1 (en) | 1998-06-26 | 2005-11-17 | Pro Surg, Inc., A California Corporation | Gel injection treatment of breast, fibroids & endometrial ablation |
WO2000000082A1 (en) | 1998-06-29 | 2000-01-06 | The Procter & Gamble Company | Disposable article having proactive sensor |
US6941171B2 (en) | 1998-07-06 | 2005-09-06 | Advanced Bionics Corporation | Implantable stimulator methods for treatment of incontinence and pain |
US6735474B1 (en) | 1998-07-06 | 2004-05-11 | Advanced Bionics Corporation | Implantable stimulator system and method for treatment of incontinence and pain |
US6027456A (en) | 1998-07-10 | 2000-02-22 | Advanced Neuromodulation Systems, Inc. | Apparatus and method for positioning spinal cord stimulation leads |
US6104960A (en) | 1998-07-13 | 2000-08-15 | Medtronic, Inc. | System and method for providing medical electrical stimulation to a portion of the nervous system |
US6002964A (en) | 1998-07-15 | 1999-12-14 | Feler; Claudio A. | Epidural nerve root stimulation |
US6042536A (en) | 1998-08-13 | 2000-03-28 | Contimed, Inc. | Bladder sling |
US6240316B1 (en) | 1998-08-14 | 2001-05-29 | Advanced Bionics Corporation | Implantable microstimulation system for treatment of sleep apnea |
IL127481A (en) | 1998-10-06 | 2004-05-12 | Bio Control Medical Ltd | Incontinence treatment device |
WO2000019939A1 (en) | 1998-10-06 | 2000-04-13 | Bio Control Medical, Ltd. | Control of urge incontinence |
US6505074B2 (en) | 1998-10-26 | 2003-01-07 | Birinder R. Boveja | Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator |
US6366814B1 (en) | 1998-10-26 | 2002-04-02 | Birinder R. Boveja | External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders |
US6356788B2 (en) | 1998-10-26 | 2002-03-12 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy for depression, migraine, neuropsychiatric disorders, partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator |
US6964643B2 (en) | 1998-11-18 | 2005-11-15 | Nugyn, Inc. | Devices and methods for treatment of incontinence |
IT1305062B1 (en) | 1998-12-23 | 2001-04-10 | Leonardo Cammilli | SINGLE INTRODUCTION CATHETER FOR MULTISITE STIMULATION OF THE FOUR CARDIAC CHAMBERS FOR TREATMENT OF PATHOLOGIES SUCH AS |
US6161029A (en) | 1999-03-08 | 2000-12-12 | Medtronic, Inc. | Apparatus and method for fixing electrodes in a blood vessel |
US6304786B1 (en) | 1999-03-29 | 2001-10-16 | Cardiac Pacemakers, Inc. | Implantable lead with dissolvable coating for improved fixation and extraction |
US20010025192A1 (en) | 1999-04-29 | 2001-09-27 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
US6055456A (en) | 1999-04-29 | 2000-04-25 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
US6341236B1 (en) | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
US6398778B1 (en) | 1999-06-18 | 2002-06-04 | Photonics Research Ontario | Optical fiber diffuser |
AUPQ202699A0 (en) | 1999-08-04 | 1999-08-26 | University Of Melbourne, The | Prosthetic device for incontinence |
US20030028232A1 (en) | 2000-01-20 | 2003-02-06 | Medtronic, Inc. | Method of lmplanting a medical electrical lead |
GB2359256B (en) | 2000-01-21 | 2004-03-03 | Sofradim Production | Percutaneous device for treating urinary stress incontinence in women using a sub-urethral tape |
US7079882B1 (en) | 2000-01-22 | 2006-07-18 | Richard Schmidt | Method and apparatus for quantifying nerve and neural-muscular integrity related to pelvic organs or pelvic floor functions |
US6582441B1 (en) | 2000-02-24 | 2003-06-24 | Advanced Bionics Corporation | Surgical insertion tool |
US6650943B1 (en) | 2000-04-07 | 2003-11-18 | Advanced Bionics Corporation | Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction |
US6616653B2 (en) | 2000-04-14 | 2003-09-09 | American Medical Systems, Inc. | Method and apparatus for coagulation of superficial blood vessels in bladder and proximal urethra |
JP4503208B2 (en) | 2000-04-25 | 2010-07-14 | インプレス メディカル, インコーポレイテッド | Method and apparatus for generating adhesions in the uterus |
US6796972B1 (en) | 2000-07-14 | 2004-09-28 | Edwards Lifesciences Llc | Catheter anchoring balloon structure with irrigation |
US6829411B2 (en) | 2000-09-01 | 2004-12-07 | Syntec, Inc. | Wide angle light diffusing optical fiber tip |
EP1326675B1 (en) | 2000-09-07 | 2011-04-13 | Mann Medical Research Organization | Apparatus for control of bowel function |
US6418930B1 (en) | 2000-11-14 | 2002-07-16 | Mayo Foundation For Medical Education And Research | Anatomic incontinence pessary |
US6971393B1 (en) | 2000-11-15 | 2005-12-06 | George Mamo | Minimally invasive method for implanting a sacral stimulation lead |
KR20030068153A (en) | 2000-11-20 | 2003-08-19 | 에디컨인코포레이티드 | Surgical instrument and method for treating female urinary incontinence |
US20020128670A1 (en) | 2000-11-22 | 2002-09-12 | Ulf Ulmsten | Surgical instrument and method for treating female urinary incontinence |
US6986764B2 (en) | 2000-12-15 | 2006-01-17 | Laserscope | Method and system for photoselective vaporization of the prostate, and other tissue |
US20020161382A1 (en) | 2001-03-29 | 2002-10-31 | Neisz Johann J. | Implant inserted without bone anchors |
US7070556B2 (en) | 2002-03-07 | 2006-07-04 | Ams Research Corporation | Transobturator surgical articles and methods |
US6612977B2 (en) | 2001-01-23 | 2003-09-02 | American Medical Systems Inc. | Sling delivery system and method of use |
US6641525B2 (en) | 2001-01-23 | 2003-11-04 | Ams Research Corporation | Sling assembly with secure and convenient attachment |
US6802807B2 (en) | 2001-01-23 | 2004-10-12 | American Medical Systems, Inc. | Surgical instrument and method |
US6952613B2 (en) * | 2001-01-31 | 2005-10-04 | Medtronic, Inc. | Implantable gastrointestinal lead with active fixation |
US6522806B1 (en) | 2001-02-16 | 2003-02-18 | Ethicon Endo-Surgury, Inc. | Optical fiber including a diffuser portion and continuous sleeve for the transmission of light |
EP1372780A4 (en) | 2001-03-30 | 2006-06-14 | Univ Case Western Reserve | Systems and methods for selectively stimulating components in, on, or near the pudendal nerve or its branches to achieve selective physiologic responses |
US6706004B2 (en) | 2001-05-31 | 2004-03-16 | Infraredx, Inc. | Balloon catheter |
SE0102312D0 (en) | 2001-06-28 | 2001-06-28 | Obtech Medical Ag | Urinary dysfunction treatment apparatus |
AU2002316732A1 (en) | 2001-07-20 | 2003-03-03 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Method and apparatus for the treatment of urinary tract dysfunction |
US6738674B2 (en) | 2001-07-25 | 2004-05-18 | Oscor Inc. | Implantable coronary sinus lead with mapping capabilities |
US7407480B2 (en) | 2001-07-27 | 2008-08-05 | Ams Research Corporation | Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele |
US6600956B2 (en) | 2001-08-21 | 2003-07-29 | Cyberonics, Inc. | Circumneural electrode assembly |
US6999819B2 (en) | 2001-08-31 | 2006-02-14 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
US6745079B2 (en) | 2001-11-07 | 2004-06-01 | Medtronic, Inc. | Electrical tissue stimulation apparatus and method |
US6712772B2 (en) | 2001-11-29 | 2004-03-30 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
US6862480B2 (en) | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
EP1461117A4 (en) | 2001-11-29 | 2011-03-16 | Ams Res Corp | Pelvic disorder treatment device |
US6899706B2 (en) | 2002-01-09 | 2005-05-31 | Inolase 2002 Ltd. | Isotopic laser for the oral cavity and use of the same |
US6911003B2 (en) | 2002-03-07 | 2005-06-28 | Ams Research Corporation | Transobturator surgical articles and methods |
US20030199961A1 (en) | 2002-04-03 | 2003-10-23 | Bjorklund Vicki L. | Method and apparatus for fixating a pacing lead of an implantable medical device |
US6964699B1 (en) | 2002-06-05 | 2005-11-15 | The United States Of America As Represented By The Secretary Of The Navy | Rocket motor exhaust scrubber |
US7292890B2 (en) | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
US7860570B2 (en) | 2002-06-20 | 2010-12-28 | Boston Scientific Neuromodulation Corporation | Implantable microstimulators and methods for unidirectional propagation of action potentials |
US7203548B2 (en) | 2002-06-20 | 2007-04-10 | Advanced Bionics Corporation | Cavernous nerve stimulation via unidirectional propagation of action potentials |
US20040015205A1 (en) | 2002-06-20 | 2004-01-22 | Whitehurst Todd K. | Implantable microstimulators with programmable multielectrode configuration and uses thereof |
US7131963B1 (en) | 2002-06-27 | 2006-11-07 | Advanced Cardiovascular Systems, Inc. | Catheters and methods of using catheters |
ES2554762T3 (en) | 2002-06-28 | 2015-12-23 | Boston Scientific Neuromodulation Corporation | Microstimulator that has autonomous power supply and directional telemetry system |
US20040242956A1 (en) | 2002-07-29 | 2004-12-02 | Scorvo Sean K. | System for controlling fluid in a body |
US7328068B2 (en) | 2003-03-31 | 2008-02-05 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith |
US20040068203A1 (en) | 2002-10-03 | 2004-04-08 | Scimed Life Systems, Inc. | Sensing pressure |
FR2847169B1 (en) | 2002-11-20 | 2005-02-18 | Vygon | DEVICE FOR LOCOREGIONAL ANESTHESIA AND METHOD FOR MANUFACTURING THE CANNULA OF THE DEVICE |
US7771345B1 (en) | 2002-12-03 | 2010-08-10 | O'donnell Pat D | Surgical instrument for treating female urinary stress incontinence |
US6847848B2 (en) | 2003-01-07 | 2005-01-25 | Mmtc, Inc | Inflatable balloon catheter structural designs and methods for treating diseased tissue of a patient |
US7112195B2 (en) | 2003-04-21 | 2006-09-26 | Cynosure, Inc. | Esophageal lesion treatment method |
US20040248979A1 (en) | 2003-06-03 | 2004-12-09 | Dynogen Pharmaceuticals, Inc. | Method of treating lower urinary tract disorders |
US20050038489A1 (en) | 2003-08-14 | 2005-02-17 | Grill Warren M. | Electrode array for use in medical stimulation and methods thereof |
US7303525B2 (en) | 2003-08-22 | 2007-12-04 | Ams Research Corporation | Surgical article and methods for treating female urinary incontinence |
US7343202B2 (en) | 2004-02-12 | 2008-03-11 | Ndi Medical, Llc. | Method for affecting urinary function with electrode implantation in adipose tissue |
US7347812B2 (en) | 2003-09-22 | 2008-03-25 | Ams Research Corporation | Prolapse repair |
US7135034B2 (en) | 2003-11-14 | 2006-11-14 | Lumerx, Inc. | Flexible array |
US8024050B2 (en) | 2003-12-24 | 2011-09-20 | Cardiac Pacemakers, Inc. | Lead for stimulating the baroreceptors in the pulmonary artery |
US8751003B2 (en) | 2004-02-11 | 2014-06-10 | Ethicon, Inc. | Conductive mesh for neurostimulation |
US8086318B2 (en) | 2004-02-12 | 2011-12-27 | Ndi Medical, Llc | Portable assemblies, systems, and methods for providing functional or therapeutic neurostimulation |
US8467875B2 (en) | 2004-02-12 | 2013-06-18 | Medtronic, Inc. | Stimulation of dorsal genital nerves to treat urologic dysfunctions |
WO2005079295A2 (en) | 2004-02-12 | 2005-09-01 | Ndi Medical, Llc | Portable assemblies, systems and methods for providing functional or therapeutic neuromuscular stimulation |
US20080132969A1 (en) | 2004-02-12 | 2008-06-05 | Ndi Medical, Inc. | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat urologic dysfunctions |
US7120499B2 (en) | 2004-02-12 | 2006-10-10 | Ndi Medical, Llc | Portable percutaneous assemblies, systems and methods for providing highly selective functional or therapeutic neuromuscular stimulation |
WO2005099809A1 (en) | 2004-04-09 | 2005-10-27 | Cook Vascular Incorporated | Modular hemostatic valve |
US7351197B2 (en) | 2004-05-07 | 2008-04-01 | Ams Research Corporation | Method and apparatus for cystocele repair |
US7500945B2 (en) | 2004-04-30 | 2009-03-10 | Ams Research Corporation | Method and apparatus for treating pelvic organ prolapse |
US20080071321A1 (en) | 2004-06-10 | 2008-03-20 | Ndi Medical, Inc. | Systems and methods of neuromodulation stimulation for the restoration of sexual function |
AU2005254016A1 (en) | 2004-06-10 | 2005-12-29 | Ndi Medical, Llc | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence |
EP1819394A1 (en) | 2004-11-08 | 2007-08-22 | Continence Control Systems International PTY Ltd. | An implantable electrode arrangement |
US7433739B1 (en) | 2004-11-30 | 2008-10-07 | Pacesetter, Inc. | Passive fixation mechanism for epicardial sensing and stimulation lead placed through pericardial access |
US7914437B2 (en) | 2005-02-04 | 2011-03-29 | Ams Research Corporation | Transobturator methods for installing sling to treat incontinence, and related devices |
US20060241733A1 (en) | 2005-04-25 | 2006-10-26 | Cardiac Pacemakers, Inc. | Atrial pacing lead |
EP1885438A4 (en) | 2005-05-13 | 2013-01-16 | Ndi Medical Inc | Systems for electrical stimulation of nerves in adipose tissue regions |
US20070043416A1 (en) | 2005-08-19 | 2007-02-22 | Cardiac Pacemakers, Inc. | Implantable electrode array |
US20070100411A1 (en) | 2005-10-27 | 2007-05-03 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
US7809443B2 (en) | 2006-01-31 | 2010-10-05 | Medtronic, Inc. | Electrical stimulation to alleviate chronic pelvic pain |
EP1991133B1 (en) | 2006-02-16 | 2018-10-24 | Boston Scientific Scimed, Inc. | Surgical articles for treating pelvic conditions |
US8195296B2 (en) | 2006-03-03 | 2012-06-05 | Ams Research Corporation | Apparatus for treating stress and urge incontinence |
US20100318098A1 (en) | 2006-04-04 | 2010-12-16 | Lund Robert E | Systems and Methods for Implanting Medical Devices |
US20090157091A1 (en) | 2006-04-04 | 2009-06-18 | Ams Research Corporation | Apparatus for Implanting Neural Stimulation Leads |
US20070255333A1 (en) | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Neuromodulation therapy for perineal or dorsal branch of pudendal nerve |
US20070253997A1 (en) | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Drug delivery to alleviate chronic pelvic pain |
US8219202B2 (en) | 2006-04-28 | 2012-07-10 | Medtronic, Inc. | Electrical stimulation of ilioinguinal nerve to alleviate chronic pelvic pain |
US20070253998A1 (en) | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain |
US20070265675A1 (en) | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
US8052731B2 (en) | 2006-06-02 | 2011-11-08 | Cardiac Pacemakers, Inc. | Medical electrical lead with expandable fixation features |
EP2032203B1 (en) | 2006-06-05 | 2013-10-23 | AMS Research Corporation | Electrical muscle stimulation to treat fecal incontinence and/or pelvic prolapse |
US7725197B2 (en) | 2006-06-15 | 2010-05-25 | Cardiac Pacemakers, Inc. | Medical electrical lead with friction-enhancing fixation features |
US20090012592A1 (en) | 2006-07-10 | 2009-01-08 | Ams Research Corporation | Tissue anchor |
US8160710B2 (en) | 2006-07-10 | 2012-04-17 | Ams Research Corporation | Systems and methods for implanting tissue stimulation electrodes in the pelvic region |
US20080039828A1 (en) | 2006-08-10 | 2008-02-14 | Jimenez Jose W | Laser Tissue Vaporization |
US7647113B2 (en) | 2006-12-21 | 2010-01-12 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
US7949409B2 (en) * | 2007-01-30 | 2011-05-24 | Cardiac Pacemakers, Inc. | Dual spiral lead configurations |
US20090259280A1 (en) | 2007-10-15 | 2009-10-15 | Kevin Wilkin | Electrical stimulation lead with bioerodible anchors and anchor straps |
US8019443B2 (en) | 2008-04-01 | 2011-09-13 | Boston Scientific Neuromodulation Corporation | Anchoring units for leads of implantable electric stimulation systems and methods of making and using |
ATE531420T1 (en) | 2009-04-28 | 2011-11-15 | Sorin Crm Sas | INTRACARDIAL SENSOR FOR STIMULATION OR DEFIBRILLATION WITH RETRACTABLE SCREW |
US20100298757A1 (en) | 2009-05-19 | 2010-11-25 | Ams Research Corporation | Adjuvant enhanced ablation |
US8936592B2 (en) | 2010-06-03 | 2015-01-20 | Ams Research Corporation | Laser tissue ablation system |
US8876804B2 (en) | 2010-12-17 | 2014-11-04 | Ams Research Corporation | Ablation device |
-
2012
- 2012-06-07 US US13/490,600 patent/US9220887B2/en active Active
-
2015
- 2015-11-20 US US14/947,502 patent/US20160089531A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4257428A (en) * | 1977-12-09 | 1981-03-24 | Barton Steven A | Retractable stimulation electrode apparatus and method |
US20020151948A1 (en) * | 1998-04-30 | 2002-10-17 | Medtronic, Inc. | Apparatus and method for expanding a simulation lead body in situ |
US20070050003A1 (en) * | 2005-08-30 | 2007-03-01 | Cardiac Pacemakers, Inc. | Device on lead to prevent perforation and/or fixate lead |
US20100049289A1 (en) * | 2007-07-10 | 2010-02-25 | Ams Research Corporation | Tissue anchor |
Also Published As
Publication number | Publication date |
---|---|
US20120316627A1 (en) | 2012-12-13 |
US9220887B2 (en) | 2015-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9889292B2 (en) | Deployable electrode lead anchor | |
US20160089531A1 (en) | Electrode lead including a deployable tissue anchor | |
US8301265B2 (en) | Selective depth electrode deployment for electrical stimulation | |
US6704605B2 (en) | Medical electrode assembly | |
US8634932B1 (en) | Minimally invasive methods for implanting a sacral stimulation lead | |
US10369354B2 (en) | Systems and method for anchoring a lead for neurostimulation of a target anatomy | |
EP2408515B1 (en) | Implantable device and tissue anchor | |
US8204569B2 (en) | Implantable medical electrical stimulation lead fixation method and apparatus | |
US7822484B1 (en) | MRI-compatible implantable lead having high impedance electrodes | |
US20070288077A1 (en) | Self-anchoring electrical lead with multiple electrodes | |
US8200343B2 (en) | Implantable medical electrical stimulation lead fixation method and apparatus | |
US8682451B2 (en) | Lead system having a non-stationary to stationary electrical interconnect and method therefor | |
JP2007505699A (en) | Fixing medical electrical leads | |
CN111741789A (en) | Neural stimulation leads for testing neural stimulation and methods of use | |
US20070255367A1 (en) | Implantable Medical Electrical Stimulation Lead Fixation Method and Apparatus | |
US9192317B2 (en) | Implantable active fixation lead with biodegradable helical tip | |
EP3389763B1 (en) | Electrical stimulation cuff devices and systems | |
WO2009094315A2 (en) | Medical electrical lead | |
WO2007146060A2 (en) | Self-anchoring electrical lead with multiple electrodes | |
US8442649B2 (en) | Systems and methods for anchoring leads of electrical stimulation systems in and around bony structures | |
WO2013025678A1 (en) | Electrode lead tissue anchor | |
US20240216675A1 (en) | Lead for the temporary stimulation of a peripheral nerve | |
WO2007047411A2 (en) | Systems and devices for stimulating an organ wall |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AMS RESEARCH, LLC, MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:AMS RESEARCH CORPATION;REEL/FRAME:037300/0607 Effective date: 20141217 |
|
AS | Assignment |
Owner name: ASTORA WOMEN'S HEALTH, LLC, MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:APHRODITE WOMEN'S HEALTH, LLC;REEL/FRAME:037473/0535 Effective date: 20150929 Owner name: APHRODITE WOMEN'S HEALTH, LLC, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMS RESEARCH, LLC;REEL/FRAME:037473/0425 Effective date: 20150227 Owner name: AMS RESEARCH, LLC, MINNESOTA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:037514/0402 Effective date: 20141217 |
|
AS | Assignment |
Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE, DELAWARE Free format text: SECURITY INTEREST;ASSIGNOR:ASTORA WOMEN'S HEALTH, LLC;REEL/FRAME:042743/0278 Effective date: 20170427 Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE Free format text: SECURITY INTEREST;ASSIGNOR:ASTORA WOMEN'S HEALTH, LLC;REEL/FRAME:042743/0278 Effective date: 20170427 |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC CORPORATION, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ASTORA WOMEN'S HEALTH, LLC;ENDO HEALTH SOLUTIONS INC.;ASTORA WOMEN'S HEALTH HOLDINGS, LLC;REEL/FRAME:043777/0895 Effective date: 20161222 Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC CORPORATION;REEL/FRAME:043778/0167 Effective date: 20161222 |
|
AS | Assignment |
Owner name: AMS RESEARCH CORPORATION, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FINLAY, MATTHEW S.;RISSMANN, WILLIAM J.;SIGNING DATES FROM 20120606 TO 20120612;REEL/FRAME:044628/0742 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |
|
AS | Assignment |
Owner name: VINTAGE PHARMACEUTICALS, LLC, NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: SLATE PHARMACEUTICALS, LLC, PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: QUARTZ SPECIALTY PHARMACEUTICALS, LLC, NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC), NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: PAR PHARMACEUTICAL, INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: GENERICS INTERNATIONAL (US), INC., NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: GENERICS BIDCO I, LLC, NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.), PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: ENDO PHARMACEUTICALS INC., PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.), PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: DAVA PHARMACEUTICALS, LLC, NEW YORK Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: DAVA INTERNATIONAL, LLC, PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: BIOSPECIFICS TECHNOLOGIES LLC, PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: BIOSPECIFICS TECHNOLOGIES CORP., PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: AUXILIUM US HOLDINGS, LLC, PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: AUXILIUM PHARMACEUTICALS, LLC, PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: ASTORA WOMEN'S HEALTH LLC, PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: ASTORA WOMEN'S HEALTH HOLDINGS, LLC, MINNESOTA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 Owner name: ACTIENT PHARMACEUTICALS LLC, PENNSYLVANIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:067240/0001 Effective date: 20240423 |